HSD will be attending the 9th annual EuPFI Conference in Warsaw, Poland on September 20-21st along with manufacturing partner Rochling Group. The European Paediatric Formulation Initiative in partnership with International Association for Pharmaceutical Technology will be hosted by the UNIVERSITY OF WARSAW, Krakowskie Przedmieście 26/28 00-927 Warsaw, Poland. This year’s theme is “Formulating better medicines for children, Meeting the needs of the children”
At the conference, HSD will be announced as a winner of the 2017 Open Innovation Device Challenge. Jeremy Bartlett of Pfizer will make the announcement. Pfizer created the challenge, along with the Institute for Pediatric Innovation, to look for innovative ideas for the development of dispensing and dosing devices for Multiparticulates.
HSD’s VP of Design and Engineering, Michael Quinn, and Rochling’s Medical Plastics‘ Business Development Manager, Valerie Duval will be accepting the Award for the new Sympfiny™ multi-particulate delivery system.
For more information on attending, click here.
For more information on Sympfiny™, click here.